Table 7.
Gene matrix of the prostate cancer group and normal control group.
No | Androgen-receptor gene mutation | Number of GSTT1 copies | Number of copies of GSTM1 | AR-protein expression level | FlnA-protein expression level |
---|---|---|---|---|---|
1 | CT | 3 | 4 | 1.99 | 3.79 |
2 | CT | 3 | 3 | 1.85 | 3.85 |
3 | CT | 3 | 3 | 1.55 | 3.96 |
4 | CT | 3 | 3 | 1.76 | 4.02 |
5 | CT | 3 | 1 | 1.51 | 3.88 |
6 | CT | 4 | 3 | 1.69 | 3.92 |
7 | CT | 3 | 3 | 2.01 | 4.10 |
8 | CT | 4 | 2 | 1.67 | 3.88 |
9 | CT | 2 | 2 | 1.72 | 3.96 |
10 | CT | 2 | 2 | 1.52 | 4.03 |
11 | CT | 2 | 2 | 1.63 | 3.86 |
12 | CT | 2 | 2 | 1.75 | 3.95 |
13 | CT | 2 | 2 | 1.68 | 3.96 |
14 | CT | 3 | 2 | 1.62 | 3.90 |
15 | CT | 3 | 2 | 1.75 | 4.01 |
16 | CT | 2 | 2 | 1.83 | 3.92 |
17 | CT | 2 | 1 | 1.62 | 3.99 |
18 | CT | 2 | 1 | 1.69 | 3.76 |
19 | CT | 2 | 1 | 1.53 | 3.88 |
20 | CT | 2 | 1 | 1.49 | 3.75 |
21 | CT | 2 | 1 | 1.92 | 3.70 |
22 | CT | 2 | 1 | 1.56 | 3.69 |
23 | CT | 1 | 1 | 1.68 | 3.69 |
24 | CT | 1 | 1 | 1.78 | 3.75 |
25 | CT | 2 | 1 | 1.75 | 3.65 |
26 | CT | 1 | 2 | 1.83 | 2.10 |
27 | CT | 1 | 1 | 1.82 | 2.05 |
28 | CT | 1 | 1 | 1.61 | 1.96 |
29 | CC | 2 | 1 | 1.66 | 1.85 |
30 | CC | 2 | 4 | 1.88 | 1.93 |
31 | CC | 3 | 3 | 1.69 | 1.72 |
32 | CC | 2 | 2 | 1.55 | 1.66 |